Kalos Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-127
Closed -$10.6K 117
2023
Q2
$10.6K Hold
127
0.02% 99
2023
Q1
$9.68K Hold
127
0.02% 213
2022
Q4
$10.5K Buy
+127
New +$10.5K 0.02% 93
2022
Q1
Sell
-2,880
Closed -$374K 306
2021
Q4
$374K Buy
2,880
+83
+3% +$10.8K 0.1% 191
2021
Q3
$364K Buy
2,797
+309
+12% +$40.2K 0.1% 186
2021
Q2
$317K Buy
2,488
+69
+3% +$8.79K 0.13% 185
2021
Q1
$302K Sell
2,419
-302
-11% -$37.7K 0.09% 222
2020
Q4
$460K Sell
2,721
-709
-21% -$120K 0.2% 139
2020
Q3
$417K Sell
3,430
-154
-4% -$18.7K 0.19% 147
2020
Q2
$392K Sell
3,584
-184
-5% -$20.1K 0.17% 135
2020
Q1
$388K Sell
3,768
-808
-18% -$83.2K 0.17% 133
2019
Q4
$435K Sell
4,576
-210
-4% -$20K 0.16% 136
2019
Q3
$366K Buy
4,786
+12
+0.3% +$918 0.15% 136
2019
Q2
$346K Buy
4,774
+1,452
+44% +$105K 0.16% 142
2019
Q1
$300K Sell
3,322
-1,348
-29% -$122K 0.19% 112
2018
Q4
$338K Buy
4,670
+458
+11% +$33.1K 0.16% 127
2018
Q3
$403K Sell
4,212
-34
-0.8% -$3.25K 0.22% 108
2018
Q2
$403K Buy
+4,246
New +$403K 0.18% 134
2018
Q1
Sell
-4,490
Closed -$381K 219
2017
Q4
$381K Buy
4,490
+96
+2% +$8.15K 0.18% 142
2017
Q3
$380K Sell
4,394
-1,830
-29% -$158K 0.24% 111
2017
Q2
$480K Sell
6,224
-298
-5% -$23K 0.44% 73
2017
Q1
$452K Sell
6,522
-215
-3% -$14.9K 0.32% 82
2016
Q4
$399K Sell
6,737
-215
-3% -$12.7K 0.32% 84
2016
Q3
$461K Sell
6,952
-14
-0.2% -$928 0.39% 78
2016
Q2
$377K Sell
6,966
-1,680
-19% -$90.9K 0.29% 106
2016
Q1
$603K Buy
8,646
+194
+2% +$13.5K 0.5% 66
2015
Q4
$605K Buy
+8,452
New +$605K 0.45% 68